Identification of candidate loci at 6p21 and 21q22 in a genome-wide association study of cardiac manifestations of neonatal lupus

Arthritis and Rheumatism

Volumn 62, Issue 11, 2010, Pages 3415-3424

  Clancy, Robert M ^a   Marion, Miranda C ^b   Kaufman, Kenneth M ^c   Ramos, Paula S ^b   Adler, Adam ^c   Harley, John B ^d   Langefeld, Carl D ^b   Buyon, Jill P ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST UNIVERSITY   (United States)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^d UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NOTCH4 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; AUTOIMMUNE DISEASE; CHILD; CHROMOSOME 21Q; CHROMOSOME 6P; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FETUS; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEART DISEASE; HLA SYSTEM; HUMAN; LUPUS VULGARIS; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION;

CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 6; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HEART DISEASES; HUMANS; INFANT, NEWBORN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; REGISTRIES;

EID: 78249257797     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.27658     Document Type: Article

References (50)

1. Chameides L, Truex RC, Vetter V, Rashkind WJ, Galioto FM Jr, Noonan JA,. Association of maternal systemic lupus erythematosus with congenital complete heart block. N Engl J Med 1977; 297: 1204 - 7.
2. Scott JS, Maddison PJ, Taylor PV, Esscher E, Scott O, Skinner RP,. Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block. N Engl J Med 1983; 309: 209 - 12.
3. Reed BR, Lee LA, Harmon C, Wolfe R, Wiggins J, Peebles C, et al. Autoantibodies to SS-A/Ro in infants with congenital heart block. J Pediatr 1983; 103: 889 - 91.
4. Buyon JP, Clancy RM, Friedman DM,. Autoimmune associated congenital heart block: integration of clinical and research clues in the management of the maternal/foetal dyad at risk. J Intern Med 2009; 265: 653 - 62.
5. Buyon J, Roubey R, Swersky S, Pompeo L, Parke A, Baxi L, et al. Complete congenital heart block: risk of occurrence and therapeutic approach to prevention. J Rheumatol 1988; 15: 1104 - 8.
6. Rivera TL, Izmirly PM, Birnbaum BK, Byrne P, Brauth JB, Katholi M, et al. Disease progression in mothers of children enrolled in the Research Registry for Neonatal Lupus. Ann Rheum Dis 2009; 68: 828 - 35.
7. Nield LE, Silverman ED, Smallhorn JF, Taylor GP, Mullen JB, Benson LN, et al. Endocardial fibroelastosis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block. J Am Coll Cardiol 2002; 40: 796 - 802.
8. Moak JP, Barron KS, Hougen TJ, Wiles HB, Balaji S, Sreeram N, et al. Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. J Am Coll Cardiol 2001; 37: 238 - 42.
9. Buyon JP, Hiebert R, Copel J, Craft J, Friedman D, Katholi M, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998; 31: 1658 - 66.
10. Friedman DM, Kim MY, Copel JA, Davis C, Phoon CK, Glickstein JS, et al. Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study. Circulation 2008; 117: 485 - 93.
11. Cimaz R, Spence DL, Hornberger L, Silverman ED,. Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies. J Pediatr 2003; 142: 678 - 83.
12. Brucato A, Frassi M, Franceschini F, Cimaz R, Faden D, Pisoni MP, et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 2001; 44: 1832 - 5.
13. Llanos C, Izmirly PM, Katholi M, Clancy RM, Friedman DM, Kim MY, et al. Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal/fetal risk factors. Arthritis Rheum 2009; 60: 3091 - 7.
14. Fritzler MJ, Pauls JD, Kinsella TD, Bowen TJ,. Antinuclear, anticytoplasmic, and anti-Sjögren?s syndrome antigen A (SS-A/Ro) antibodies in female blood donors. Clin Immunol Immunopathol 1985; 36: 120 - 8.
15. Harmon CE, Lee LA, Huff JC, Norris DA, Weston WL,. The frequency of autoantibodies to the SS-A/Ro antigen in pregnancy sera [abstract]. Arthritis Rheum 1984; 27 Suppl 4: S20.
16. Siren MK, Julkunen H, Kaaja R,. The increasing incidence of isolated congenital heart block in Finland. J Rheumatol 1998; 25: 1862 - 4.
17. Gawkrodger DJ, Beveridge GW,. Neonatal lupus erythematosus in four successive siblings born to a mother with discoid lupus erythematosus. Br J Dermatol 1984; 111: 683 - 7.
18. Cooley HM, Keech CL, Melny BJ, Menahem S, Morahan G, Kay TW,. Monozygotic twins discordant for congenital complete heart block. Arthritis Rheum 1997; 40: 381 - 4.
19. Siren MK, Julkunen H, Kaaja R, Ekblad H, Koskimies S,. Role of HLA in congenital heart block: susceptibility alleles in children. Lupus 1999; 8: 60 - 7.
20. Barquero Genoves IM, Figueras Aloy J, Guerola Serret M, Jimenez Gonzalez R,. A complete congenital heart block in twins. An Esp Pediatr 1996; 44: 164 - 6. In Spanish.
21. Harley JB, Alarcon-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP, Moser KL, et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008; 40: 204 - 10.
22. Hindorff LA, Junkins HA, Mehta JP, Manolio TA,. A catalog of published genome-wide association studies. Washington: NIH/National Human Genome Research Institute. URL:.
23. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D,. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38: 904 - 9.
24. Narayanaswamy C, Raghavarao D,. Principal component analysis of large dispersion matrices. Appl Stat 1991; 40: 309 - 16.
25. Velicer WF,. Determining the number of components from the matrix of partial correlations. Psychometrika 1976; 41: 321 - 7.
26. Tracy C, Widom H,. Level-spacing distributions and the Airy kernel. Commun Math Phys 1994; 159: 151 - 74.
27. Patterson N, Price AL, Reich D,. Population structure and eigenanalysis. PLoS Genet 2006; 2: e190.
28. Graham RR, Ortmann W, Rodine P, Espe K, Langefeld C, Lange E, et al. Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE. Eur J Hum Genet 2007; 15: 823 - 30.
29. Harley JB, Reichlin M, Arnett FC, Alexander EL, Bias WB, Provost TT,. Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren?s syndrome. Science 1986; 232: 1145 - 7.
30. Scofield RH, Frank MB, Neas BR, Horowitz RM, Hardgrave KL, Fujisaku A, et al. Cooperative association of T cell β receptor and HLA-DQ alleles in production of anti-Ro in systemic lupus erythematosus. Clin Immunol Immunopathol 1994; 72: 335 - 41.
31. Guggenbuhl P, Veillard E, Quelvenec E, Jego P, Semana G, Jean S, et al. Analysis of TNFα microsatellites in 35 patients with primary Sjögren?s syndrome. Joint Bone Spine 2000; 67: 290 - 5.
32. Rood MJ, van Krugten MV, Zanelli E, van der Linden MW, Keijsers V, Schreuder GM, et al. TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 2000; 43: 129 - 34.
33. Werth VP, Zhang W, Dortzbach K, Sullivan K,. Association of a promoter polymorphism of tumor necrosis factor-α with subacute cutaneous lupus erythematosus and distinct photoregulation of transcription. J Invest Dermatol 2000; 115: 726 - 30.
34. Martinez A, Fernandez-Arquero M, Pascual-Salcedo D, Conejero L, Alves H, Balsa A, et al. Primary association of tumor necrosis factor-region genetic markers with susceptibility to rheumatoid arthritis. Arthritis Rheum 2000; 43: 1366 - 70.
35. Sashio H, Tamura K, Ito R, Yamamoto Y, Bamba H, Kosaka T, et al. Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn?s disease, respectively. Immunogenetics 2002; 53: 1020 - 7.
36. Clancy RM, Backer CB, Yin X, Kapur RP, Molad Y, Buyon JP,. Cytokine polymorphisms and histologic expression in autopsy studies: contribution of TNF-α and TGF-β1 to the pathogenesis of autoimmune-associated congenital heart block. J Immunol 2003; 171: 3253 - 61.
37. Miranda-Carus ME, Askanase AD, Clancy RM, Di Donato F, Chou TM, Libera MR, et al. Anti-SSA/Ro and anti-SSB/La autoantibodies bind the surface of apoptotic fetal cardiocytes and promote secretion of TNF-α by macrophages. J Immunol 2000; 165: 5345 - 51.
38. Clancy R, Yin X, Askanese A, Miranda-Carus E, Nelson JL, Sestak A, et al. HLA-DBR1 relationships in neonatal lupus families [abstract]. Arthritis Rheum 2003; 48 Suppl 9: S410 - 1.
39. Nair RP, Stuart PE, Nistor I, Hiremagalore R, Chia NV, Jenisch S, et al. Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am J Hum Genet 2006; 78: 827 - 51.
40. Clancy RM, Kapur RP, Molad Y, Askanase AD, Buyon JP,. Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage/fibroblast crosstalk in the pathologic cascade leading to congenital heart block. Arthritis Rheum 2004; 50: 173 - 82.
41. Clancy RM, Neufing PJ, Zheng P, O'Mahony M, Nimmerjahn F, Gordon TP, et al. Impaired clearance of apoptotic cardiocytes is linked to anti-SSA/Ro and-SSB/La antibodies in the pathogenesis of congenital heart block. J Clin Invest 2006; 116: 2413 - 22.
42. Yi H, Fujimura Y, Ouchida M, Prasad DD, Rao VN, Reddy ES,. Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias. Oncogene 1997; 14: 1259 - 68.
43. Yuan L, Nikolova-Krstevski V, Zhan Y, Kondo M, Bhasin M, Varghese L, et al. Antiinflammatory effects of the ETS factor ERG in endothelial cells are mediated through transcriptional repression of the interleukin-8 gene. Circ Res 2009; 104: 1049 - 57.
44. Im YH, Kim HT, Lee C, Poulin D, Welford S, Sorensen PH, et al. EWS-FLI1, EWS-ERG, and EWS-ETV1 oncoproteins of Ewing tumor family all suppress transcription of transforming growth factor β type II receptor gene. Cancer Res 2000; 60: 1536 - 40.
45. Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon R, Callis KP, et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 2007; 80: 273 - 90.
46. Kolodsick JE, Toews GB, Jakubzick C, Hogaboam C, Moore TA, McKenzie A, et al. Protection from fluorescein isothiocyanate-induced fibrosis in IL-13-deficient, but not IL-4-deficient, mice results from impaired collagen synthesis by fibroblasts. J Immunol 2004; 172: 4068 - 76.
47. Fichtner-Feigl S, Strober W, Kawakami K, Puri RK, Kitani A,. IL-13 signaling through the IL-13α2 receptor is involved in induction of TGF-β1 production and fibrosis. Nat Med 2006; 12: 99 - 106.
48. Scotton CJ, Chambers RC,. Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest 2007; 132: 1311 - 21.
49. Sonesson SE, Salomonsson S, Jacobsson LA, Bremme K, Wahren-Herlenius M,. Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies. Arthritis Rheum 2004; 50: 1253 - 61.
50. Rein AJ, Mevorach D, Perles Z, Gavri S, Nadjari M, Nir A, et al. Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies: a prospective, observational, fetal kinetocardiogram-based study. Circulation 2009; 119: 1867 - 72.